CLINICAL_TRIALS
trial_result
· 2025-07-31
Clinical Trial Update: An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer [Phase 1, Phase 2]
Summary
An exploratory Phase 1/2 trial evaluating whether NK cell–assisted therapy can prevent chemotherapy-induced bone marrow suppression in ovarian cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Anhui Provincial Cancer Hospital | Conditions: Ovary Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING